One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans who ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.

Wearable device data could predict New York Heart Association functional class similarly to clinical measures and six-minute walk test. HealthDay News — For patients with atrial fibrillation, digoxin ...

Heart disease has been the leading cause of death in the U.S. for 100 years, according to the American Heart Association’s 2024 Heart Disease and Stroke Statistics report. For decades, beta-blockers ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Beta-blockers did not improve clinical outcomes after ...

The 3 common mainstays of angina therapy are beta-blockers, calcium channel blockers, and nitrates. These medicines treat the chest pain and provide other benefits as well. Isosorbide is a nitrate, ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...

Medically reviewed by Mary Choy, PharmD Metoprolol is a medicine used to treat high blood pressure and heart problems, but it ...

Without question, there is a fair deal of negative stigma surrounding traditional psychopharmaceutical treatments for problems such as anxiety, depression, and panic. While these medications of ...

MADRID -- Beta-blockers may be relegated to a smaller role for secondary prevention after myocardial infarction (MI) in contemporary practice, based on the arrival of three new trials from Europe.